Movantik for Opioid-Related Esophageal Disorders

NCT02998606 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Investigator left Institution

Conditions

Opioid-Induced Disorders
Esophagus Disorder

Interventions

DRUG: Naloxegol
DRUG: Placebo Oral Capsule

Sponsor

Temple University

Collaborators

[object Object]